Skip to main content
. Author manuscript; available in PMC: 2011 May 11.
Published in final edited form as: Arch Dermatol. 2010 May;146(5):529–533. doi: 10.1001/archdermatol.2010.89

Table 2. Summary of Laboratory Findings for the Proband and her Family.

Test, units (reference range) Sib 1 – proband Sib 2 – affected Sib 3 – affected Sib 4 – unaffected Sib 5 – unaffected Mother Father
Hematocrit, % (34-48) 29 33 32 36 32 38 41
Serum ferritin, ng/mL (10-290) 317 50 362 18 30 21 76
Urine total porphyrins, nmol/24 hours (0-300) 6,294 511 3,495 108 40 123 16
Urine porphyrin pattern, %:
Uro (0-30) 33 22 22 N/A N/A N/A N/A
Heptacarboxyl (0-5) 25 29 27
Hexacarboxyl (0-5) 10 13 12
Pentacarboxyl (0-5) 9 11 13
Copro (50-100) 23 25 26
Plasma total porphyrins, μg/dL (0-0.9) 38.1 16.6 32.3 0.2 0.2 0.3 0.2
Fluorescence peak, nm 619 620 619 No peak No peak No peak No peak
Erythrocyte protoporphyrin, μg/dL (20-80) 1,690* 1,749* 2,058* 42 68 62 58
Erythrocyte UROD activity, nmol/mL RBC/hr (35-60) 16.2 13.8 15 45.8 53.6 38.1 43.8
UROD mutation del1053/ins10 V166A del1053/ins10 V166A del1053/ins10 V166A V166A V166A del1053/ins10 V166A
HFE mutation H63D - H63D N/A N/A - N/A

N/A, not available; sib, sibling; abnormal values are italicized

*

∼70% Zn-protoporphyrin.